Article Details

Nippon Shinyaku and Capricor Therapeutics Enter into an Exclusive Partnership for ...

Retrieved on: 2022-01-25 20:10:12

Tags for this article:

Click the tags to see associated articles and topics

Nippon Shinyaku and Capricor Therapeutics Enter into an Exclusive Partnership for .... View article details on hiswai:

Excerpt

Exosomes (extracellular vesicles) secreted by CAP-1002 are thought to be the mechanism of action of CAP-1002 and have been shown to reduce ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up